MannKind | Crediti Commerciali



Trade Debtors Cambiamento Data
Adma Biologics USD 50M 141K 2024-12
Dynavax Technologies USD 46.91M 28.37M 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Halozyme Therapeutics USD 308.46M 22.71M 2024-12
Insmed USD 52.01M 9.7M 2024-12
MacroGenics USD 8.75M 2.56M 2024-09
MannKind USD 37.1M 18.92M 2024-12
Merck USD 11.12B 1.06B 2024-12
Novo Nordisk DKK 79.63B 3.5B 2024-09
Pfizer USD 14.78B 2.92B 2024-12
Sanofi 8.8B 2.24B 2024-06
Xencor USD 60.85M 50.64M 2024-12



MannKind Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.